​​

• Assessing cognitive performance in radiologically isolated syndrome

• Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy

• Assessing cognitive performance in radiologically isolated syndrome

• Serum biochemical markers for brain damage in children with emphasis on mild head injury

• Immunoglobulin treatment for severe childhood epilepsy

• Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients

• Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors

• Parry-Romberg syndrome presenting as status migrainosus

• Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage